Table 4 Biomarker concentration in renal transplant recipients with IgA nephropathy as underlying disease leading to TX
Biomarker concentration, median [IQR] | ||||||
|---|---|---|---|---|---|---|
Baseline (n = 159) | 6 months (n = 158) | 12 months (n = 155) | ||||
R group (n = 42) | NR group (n = 117) | R group (n = 42) | NR group (n = 116) | R group (n = 40) | NR group (n = 115) | |
Total IgA (mg/ml) | 1.97 [1.53, 2.87] | 2.31 [1.75, 3.33] | 1.82 [1.36, 2.26] | 2.13 [1.39, 2.8] | 1.86 [1.26, 2.7] | 2.1 [1.5, 2.86] |
Total IgG (mg/ml) | 7.96 [5.46, 10.48] | 7.48 [5.88, 9.85] | 6.66 [5.3, 8.6] | 6.6 [5.4, 8.29] | 7.04 [5.89, 8.28] | 7.43 [6.06, 9.11] |
Gd-IgA1 (OD) | 0.46 [0.42, 0.49] | 0.46 [0.41, 0.5] | 0.46 [0.4, 0.49] | 0.46 [0.43, 0.5] | 0.46 [0.43, 0.49] | 0.47 [0.41, 0.5] |
IgA – IgG IC (OD) | 0.91 [0.8, 1.03] | 0.88 [0.76, 0.99] | 0.84 [0.76, 0.99] | 0.8 [0.69, 0.92] | 0.87 [0.77, 0.98] | 0.85 [0.71, 0.97] |